Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:1357 |
Name | maxillary sinus cancer |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | DOID:2372 |
Path | disease disease of cellular proliferation cancer organ system cancer respiratory system cancer paranasal sinus cancer maxillary sinus cancer |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
MSH6 negative | Pembrolizumab | maxillary sinus cancer | sensitive | detail... |
MLH1 negative | Pembrolizumab | maxillary sinus cancer | sensitive | detail... |
FGFR1 act mut | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
FGFR1 fusion | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
FGFR2 act mut | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
FGFR2 fusion | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
FGFR3 act mut | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
FGFR3 fusion | Erdafitinib | maxillary sinus cancer | sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|